new glp 1 gip drug In a recent study published in Nature, researchers discovered a five-target called lanifibranor that outperforms GLP-1/GIP therapy in obese diabetic mice. This single-molecule compound activates incretin receptor-expressing cells and PPARα/γ/δ How GLP-1 medications are transforming

Current formulations of GLP-1 analogs rely primarily on subcutaneous injections, which may pose challenges to patient convenience and long-term adherence

Customized Formulations | Precision Engineering | Scalable Solutions | Comprehensive Reports & COA Consult Our Experts Home Solutions Cosmetic Solutions Liposomal Glutathione Development for Skin Care Unlocking the Power of Liposomal Glutathione for Advanced Skin Care Development Glutathione (GSH), often hailed as the "master antioxidant," possesses immense potential in cosmeceuticals for skin brightening, anti-aging, and detoxification

Isso j aconteceu com voc

Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters

Zhang W, Tung CH

Hata A, Doi Y, Ninomiya T, Mukai N, Hirakawa Y, Hata J,